Delaware facility News

Merck & Co. Inc. Unveils $1 Billion Investment in Delaware for New Drug Manufacturing Facility

Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce drugs, including a new version of Keytruda, creating 4,500 jobs by 2030, aligning with US d...

Merck & Co. Inc. Unveils $1 Billion Investment in Delaware for Cutting-Edge Drug Manufacturing

Merck & Co. Inc. announces a $1 billion investment in Delaware for a new facility to produce innovative drugs and a new version of Keytruda, creating 4,500 jobs and aligning with U...